+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neoantigen Cancer Vaccine"

Global Neoantigen Cancer Vaccine Market by Product, Technology, Delivery Mechanism, Neoantigen Type, Route of Administration, Application - Forecast 2024-2030 - Product Thumbnail Image

Global Neoantigen Cancer Vaccine Market by Product, Technology, Delivery Mechanism, Neoantigen Type, Route of Administration, Application - Forecast 2024-2030

  • Report
  • March 2024
  • 190 Pages
  • Global
From
Global Neoantigen Cancer Vaccine Market: Focus on Approach, Line of Therapy, Type, Application, Treatment Strategy, and Country-Wise Analysis - Analysis and Forecast, 2024-2031 - Product Thumbnail Image

Global Neoantigen Cancer Vaccine Market: Focus on Approach, Line of Therapy, Type, Application, Treatment Strategy, and Country-Wise Analysis - Analysis and Forecast, 2024-2031

  • Report
  • February 2022
  • 199 Pages
  • Global
From
Global Cancer Vaccine Market & Clinical Trials Outlook 2028 - Product Thumbnail Image

Global Cancer Vaccine Market & Clinical Trials Outlook 2028

  • Report
  • July 2022
  • 600 Pages
  • Global
From
Global Neoantigen Cancer Vaccine Market, By Product, By Neoantigen Type, By Route of Administration, By Cell, By Technology, By Delivery Mechanism, By Application, By Region, Competition, Forecast & Opportunities, 2026 - Product Thumbnail Image

Global Neoantigen Cancer Vaccine Market, By Product, By Neoantigen Type, By Route of Administration, By Cell, By Technology, By Delivery Mechanism, By Application, By Region, Competition, Forecast & Opportunities, 2026

  • Report
  • July 2021
  • 284 Pages
  • Global
From
Global Neoantigen Cancer Vaccine Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Neoantigen Cancer Vaccine Market Report and Forecast 2023-2031

  • Report
  • July 2023
  • 140 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

The Neoantigen Cancer Vaccine market is a subset of the larger Cancer Vaccine market. Neoantigen Cancer Vaccines are a type of personalized cancer immunotherapy that uses a patient’s own tumor-specific mutations to create a vaccine tailored to their individual cancer. These vaccines are designed to stimulate the patient’s immune system to recognize and attack cancer cells. Neoantigen Cancer Vaccines are still in the early stages of development, but have shown promise in clinical trials. The Neoantigen Cancer Vaccine market is expected to grow as more personalized cancer treatments become available. Companies in the market include Moderna, BioNTech, CureVac, and Inovio Pharmaceuticals. Show Less Read more